Skip to content
BidBenchmark

Contract award

GLYCAN THERAPEUTICS CORPORATION

IGF::OT::IGF CHEMOENZYMATIC SYNTHESIS OF HEPARIN SULFATE
PIID
HHSN261201500019C
Award key
CONT_AWD_HHSN261201500019C_7529_-NONE-_-NONE-
Recipient UEI
KYG3DZSMH4R7
Source as of
Current award value
$1,646,5413
Obligated to date
$1,646,5412
Potential with options
$1,646,5413
Awarding agency
Department of Health and Human ServicesNational Institutes of Health
Place of performance
Chapel Hill, North Carolina
Set-aside
Small Business Set-Aside - Total
Pricing
Cost Plus Fixed Fee
Competition
Full and Open Competition after Exclusion of Sources7 offers received
Period of performance
Sep 18, 2015Mar 17, 2019Through Mar 17, 2019 if all options are exercised
Benchmark category
Unclassified

Transaction history

Every action recorded against this award, in the order the government reported them.

ModAction dateReasonObligationValue at action
0Sep 17, 2015Initial award$952,831.00$1,646,541.00
1Sep 24, 2015M$0.00$1,646,541.00
2Jan 19, 2016M$0.00$1,646,541.00
3Apr 15, 2016M$0.00$1,646,541.00
4Apr 14, 2017M$0.00$1,646,541.00
5Sep 11, 2017D$693,710.00$1,646,541.00
6Nov 8, 2017M$0.00$1,646,541.00
7Sep 5, 2018M$0.00$1,646,541.00

Provenance

Which source record produced each displayed rollup figure.

FieldSourceFileRetrievedParserArtifact hash
awarding_agency_idUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.2d4d16ba91ad6
contractor_idUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.2d4d16ba91ad6
current_award_valueUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.2d4d16ba91ad6
naics_codeUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.2d4d16ba91ad6
potential_award_valueUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.2d4d16ba91ad6
psc_codeUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.2d4d16ba91ad6
total_obligatedUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.2d4d16ba91ad6

Sources and method

Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.

This page is a record of one federal award, assembled from the transactions the government published against it. Note 1 describes where the rollup came from. Values are award values, not unit prices.

  1. 1Rollup values derive from 8 transaction records parsed from USAspending.gov, retrieved Aug 10, 2026 by transform awards@2026.08.1.
  2. 2Obligations are the sum of signed federal action obligations across all transactions; deobligations are negative and remain negative.
  3. 3Current and potential award values are taken from the latest reported action, not summed across modifications.
HHSN261201500019C — GLYCAN THERAPEUTICS CORPORATION · BidBenchmark